Juli P. Miller

Juli P. Miller, PhD, currently serves as Vice President of Corporate Affairs and Investor Relations at Adaptimmune, where employment commenced in August 2016, following roles as Vice President of Investor Relations and Senior Director. Previous experience includes positions at Jazz Pharmaceuticals as Associate Director, driving regulatory and medical writing efforts for NDA submissions, and at Shire as Manager, leading medical writing on various submissions. Early career roles involved serving as Senior Medical Writer at ViroPharma Incorporated and Medical Writer at Synchrogenix, a Certara company. Educational qualifications include a PhD in Immunology from the University of Pennsylvania, a Master's in Immunology from the Imperial Cancer Research Fund, and a Bachelor's degree from Bryn Mawr College.